German multinational medtech firm Siemens Healthineers has introduced the first AI-enhanced eco-friendly multi-testing diagnostic analyser in India at diagnostic centre Mahajan Imaging & Labs.
Germany-headquartered healthcare conglomerate Fresenius reported strong revenue growth in its second-quarter results on July 31. But net profit for the quarter was negative, mainly due to discontinued operations at the group's Vamed subsidiary.
The European clinical lab market has been moving towards consolidation for some time, a trend that is expected to continue.
During the final panel session of the HBI 2024 conference, "Laboratory Diagnostics – Growth Beyond Consolidation," the panellists agreed that the laboratory sector is already highly consolidated, and collectively debated as to whether there is still room for further consolidation within Europe.
The EU’s healthcare workforce is in crisis, with health systems described as “underprepared, understaffed, and facing underinvestment.” Since the onset of the pandemic in 2020, healthcare in the EU has been grappling with significant challenges.
Europe has faced numerous healthcare workforce strikes this year. On June 18, thousands of workers from private hospitals, clinics, and retirement homes in France went on strike. Earlier, in February, healthcare professionals in Germany protested in Berlin for better wages.
Pan-European Spanish healthcare real estate investor Healthcare Activos has launched a new investment fund worth €650 million. This is the REIT’s second fund, and will, in contrast to the first fund, be primarily focused on making investments outside of Spain and Portugal. Jorge Guarner, Activos’ President and Founder, tells us more.
Two weeks ago Germany’s cabinet government approved Health Minister Karl Lauterbach’s hospital reform. The current watered-down reform’s key feature is a proposal to move the sector’s reimbursement model away from fee-per-service payments, purportedly to reduce the incentive to overtreat. However, experts tell us the real motivation is still to shut down smaller unspecialised hospitals. Will it succeed in doing so?
German Health Minister Karl Lauterbach’s intention to ban investors from owning outpatient facilities appears to no longer have any realistic chance of being passed. Investors and advisors are consequently gearing up for a flurry of deals in H2 from pent-up demand.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
